Risk Factors of Klebsiella pneumoniae Infections in Pediatric Healthcare Settings
Open Access
- 16 May 2020
- journal article
- research article
- Published by LLC Numicom in Epidemiology and Vaccinal Prevention
- Vol. 19 (2) , 40-47
Abstract
Relevance. Klebsiella pneumoniae is a major cause of severe healthcare-associated infections in children, representing one of the six most widespread multidrug-resistant microorganisms worldwide and requiring the implementation of population-wide treatment strategies.Aim. To study the risk factors for Klebsiella spread in pediatric healthcare settings.Materials and Methods. Here we performed a descriptive retrospective epidemiological study of Klebsiella spp. cases in pediatric units across the entire Kemerovo region (2012–2019). In total, we documented 27,852 treatment outcomes. We further selected 52 confirmed cases and assessed their risk profiles in comparison with 738 condition-matched control children.Results. Average incidence of Klebsiella spp. detection in pediatric healthcare settings was 78.52 per 1,000 patients (95% CI = 75.42–81.74). We revealed a declining incidence of Klebsiella pneumoniae infection in the region, with notable 4-year cyclicity. The proportion of Klebsiella pneumoniae-infected patients increased 2-fold after 5 days of antibiotic therapy. Among the risk factors of Klebsiella pneumonia infection were artificial feeding (OR = 9,21, 95% = 3,31–35,45, р = 0,0001), assisted ventilation (OR = 7,36, 95% CI = 3,92–14,0], р = 0,0001), use of nebulizers (OR = 5,34, 95% CI =2,49 – 10,9], р=0,0001), airway management (OR = 4,62, 95% CI =2,49–8,56, р = 0,0001), preterm birth (OR = 2,55, 95% CI =1,38 – 4,69, р=0,001), low body weight (OR = 2,48, 95% CI = 1,34–4,56, р = 0,002), enema administration (OR = 1,80, 95% CI = 0,78–3,81, р = 0,088), and nasogastric intubation (OR = 1,79, 95% CI = 0,85–3,54, р = 0,065).Conclusions. The incidence of Klebsiella pneumoniae infections is currently lowering and has 4-year cyclicity. Antimicrobial treatment is associated with 2-fold increased risk if administered for ≥ 5 days. A number of healthcare-associated risk factors of Klebsiella pneumoniae infections have been found.Keywords
This publication has 11 references indexed in Scilit:
- Whole-Genome Sequencing of Klebsiella pneumoniae Isolates to Track Strain Progression in a Single Patient With Recurrent Urinary Tract InfectionFrontiers in Cellular and Infection Microbiology, 2019
- Assessment of device-associated infection rates in teaching hospitals in Islamic Republic of IranEastern Mediterranean Health Journal, 2019
- Prevalence Acinetobacter spp. in Kemerovo Region Healthcare SettingsEpidemiology and Vaccinal Prevention, 2018
- An observational case study of hospital associated infections in a critical care unit in Astana, KazakhstanAntimicrobial Resistance & Infection Control, 2018
- High Prevalence of Hypervirulent Klebsiella pneumoniae Infection in China: Geographic Distribution, Clinical Characteristics, and Antimicrobial ResistanceAntimicrobial Agents and Chemotherapy, 2016
- Evaluation of Biofilm Formation Among Klebsiella pneumoniae Isolates and Molecular Characterization by ERIC-PCRJundishapur Journal of Microbiology, 2016
- Klebsiella pneumoniae: characteristics of carbapenem resistance and virulence factorsActa Biochimica Polonica, 2015
- Carbapenemase-Producing Klebsiella pneumoniae, a Key Pathogen Set for Global Nosocomial DominanceAntimicrobial Agents and Chemotherapy, 2015
- Molecular Pathogenesis of Klebsiella PneumoniaeFuture Microbiology, 2014
- Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemasesThe Lancet Infectious Diseases, 2013